50440-30-7

Basic information

• Product Name: 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide
• CAS NO: 50440-30-7
• Molecular Formula: C₂₇H₂₀N₆O₃
• Molecular Weight: 476.4861
• Mol File: 50440-30-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 662.7°C at 760 mmHg
• Flash Point: 354.6°C
• Density: 1.431g/cm³
• Vapor Pressure: 1.96E-17mmHg at 25°C
• Refractive Index: 1.783
• CAS DataBase Reference: 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide(50440-30-7)
• EPA Substance Registry System: 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide(50440-30-7)

Safety Data

• Hazardous Substances Data: 50440-30-7(Hazardous Substances Data)

Usage

Description

4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide is a complex organic chemical compound characterized by a benzamide core, with a 6-nitroquinolin-4-yl group and a pyridin-4-ylamino group attached to the amine nitrogen. Its intricate molecular structure suggests potential pharmaceutical applications, possibly due to its structural resemblance to other biologically active molecules, which may confer specific biological activities, such as targeting particular receptors or enzymes. Further investigation is required to elucidate its full spectrum of potential uses and effects.

Uses

Used in Pharmaceutical Industry:
4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide is used as a potential pharmaceutical agent for its possible biological activity, which may include targeting specific receptors or enzymes important in various disease pathways. Its complex structure and potential interactions with biological systems make it a candidate for further research and development in drug discovery.
Used in Research and Development:
In the field of medicinal chemistry, this compound serves as a subject for research to explore its potential therapeutic effects and mechanisms of action. It may be utilized in assays and screenings to identify its interactions with biological targets, contributing to the advancement of new drug leads and therapeutic strategies.

Upstream product

• 611-36-9 quinolin-4-ol 
• 23432-42-0 4-hydroxy-6-nitro-quinoline 
• 66493-39-8 4-(N-tert-butoxycarbonyl)aminobenzoic acid 
• 60172-08-9 N₁-(4-pyridinyl)-1,4-benzenediamine 
• 23552-71-8 C₁₈H₁₄N₄O₃ 
• 13675-94-0 4-chloro-6-nitroquinoline 
• 23625-78-7 4-[p-(4-pyridylamino)phenylcarbamoyl]aniline 

Relevant articles and documents

AKT3 MODULATORS

Compounds of Formula la, lb, or Ic, are described, where the various substituents are defined herein. The compounds can modulate a property or effect of Akt3 in vitro or in vivo, and can also be used, individually or in combination with other agents, in the prevention or treatment of a variety of conditions. Methods for synthesizing the compounds are described. Pharmaceutical compositions and methods of using these compounds or compositions, individually or in combination with other agents or compositions, in the prevention or treatment of a variety of conditions are also described.